[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Biologics and Biosimilars Market Professional Survey Report Forecast 2017-2021

March 2017 | 124 pages | ID: GA973B183C6EN
S&P Consulting

US$ 2,720.00 US$ 3,400.00 -20 %

E-mail Delivery (PDF), E-mail Delivery (Word), E-mail Delivery (Excel), E-mail Delivery (PowerPoint)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies Biologics and Biosimilars in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2017, and forecast to 2021.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Pfizer
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Novo Nordisk
Novartis
company 9
By types, the market can be split into
Biologics
Biosimilars
  • Type III
By Application, the market can be split into
Tumor
Diabetes
Cardiovascular
By Regions, this report covers (we can add the regions/countries as you want)
  • North America
  • China
  • Europe
  • Southeast Asia
  • Japan
  • India
1 INDUSTRY OVERVIEW OF BIOLOGICS AND BIOSIMILARS

1.1 Definition and Specifications of Biologics and Biosimilars
  1.1.1 Definition of Biologics and Biosimilars
  1.1.2 Specifications of Biologics and Biosimilars
1.2 Classification of Biologics and Biosimilars
  1.2.1 Biologics
  1.2.2 Biosimilars
  1.2.3 Type III
1.3 Applications of Biologics and Biosimilars
  1.3.2 Tumor
  1.3.3 Diabetes
  1.3.4 Cardiovascular
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF BIOLOGICS AND BIOSIMILARS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Biologics and Biosimilars
2.3 Manufacturing Process Analysis of Biologics and Biosimilars
2.4 Industry Chain Structure of Biologics and Biosimilars

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF BIOLOGICS AND BIOSIMILARS

3.1 Capacity and Commercial Production Date of Global Biologics and Biosimilars Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Biologics and Biosimilars Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Biologics and Biosimilars Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Biologics and Biosimilars Major Manufacturers in 2016

4 GLOBAL BIOLOGICS AND BIOSIMILARS OVERALL MARKET OVERVIEW

4.1 2012-2017 Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017 Global Biologics and Biosimilars Capacity and Growth Rate Analysis
  4.2.2 2016 Biologics and Biosimilars Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017 Global Biologics and Biosimilars Sales and Growth Rate Analysis
  4.3.2 2016 Biologics and Biosimilars Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017 Global Biologics and Biosimilars Sales Price
  4.4.2 2016 Biologics and Biosimilars Sales Price Analysis (Company Segment)

5 BIOLOGICS AND BIOSIMILARS REGIONAL MARKET ANALYSIS

5.1 North America Biologics and Biosimilars Market Analysis
  5.1.1 North America Biologics and Biosimilars Market Overview
  5.1.2 North America 2012-2017 Biologics and Biosimilars Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017 Biologics and Biosimilars Sales Price Analysis
  5.1.4 North America 2016 Biologics and Biosimilars Market Share Analysis
5.2 China Biologics and Biosimilars Market Analysis
  5.2.1 China Biologics and Biosimilars Market Overview
  5.2.2 China 2012-2017 Biologics and Biosimilars Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017 Biologics and Biosimilars Sales Price Analysis
  5.2.4 China 2016 Biologics and Biosimilars Market Share Analysis
5.3 Europe Biologics and Biosimilars Market Analysis
  5.3.1 Europe Biologics and Biosimilars Market Overview
  5.3.2 Europe 2012-2017 Biologics and Biosimilars Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017 Biologics and Biosimilars Sales Price Analysis
  5.3.4 Europe 2016 Biologics and Biosimilars Market Share Analysis
5.4 Southeast Asia Biologics and Biosimilars Market Analysis
  5.4.1 Southeast Asia Biologics and Biosimilars Market Overview
  5.4.2 Southeast Asia 2012-2017 Biologics and Biosimilars Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017 Biologics and Biosimilars Sales Price Analysis
  5.4.4 Southeast Asia 2016 Biologics and Biosimilars Market Share Analysis
5.5 Japan Biologics and Biosimilars Market Analysis
  5.5.1 Japan Biologics and Biosimilars Market Overview
  5.5.2 Japan 2012-2017 Biologics and Biosimilars Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017 Biologics and Biosimilars Sales Price Analysis
  5.5.4 Japan 2016 Biologics and Biosimilars Market Share Analysis
5.6 India Biologics and Biosimilars Market Analysis
  5.6.1 India Biologics and Biosimilars Market Overview
  5.6.2 India 2012-2017 Biologics and Biosimilars Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017 Biologics and Biosimilars Sales Price Analysis
  5.6.4 India 2016 Biologics and Biosimilars Market Share Analysis

6 GLOBAL 2012-2017 BIOLOGICS AND BIOSIMILARS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017 Biologics and Biosimilars Sales by Type
6.2 Different Types of Biologics and Biosimilars Product Interview Price Analysis
6.3 Different Types of Biologics and Biosimilars Product Driving Factors Analysis
  6.3.1 General keyboard membrane of Biologics and Biosimilars Growth Driving Factor Analysis
  6.3.2 Transparent keyboard membrane of Biologics and Biosimilars Growth Driving Factor Analysis
  6.3.3 Simulation keyboard membrane of Biologics and Biosimilars Growth Driving Factor Analysis
  6.3.4 Colorful keyboard membrane of Biologics and Biosimilars Growth Driving Factor Analysis
  6.3.5 Other of Biologics and Biosimilars Growth Driving Factor Analysis

7 GLOBAL 2012-2017 BIOLOGICS AND BIOSIMILARS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017 Biologics and Biosimilars Consumption by Application
7.2 Different Application of Biologics and Biosimilars Product Interview Price Analysis
7.3 Different Application of Biologics and Biosimilars Product Driving Factors Analysis
  7.3.1 Office Use of Biologics and Biosimilars Growth Driving Factor Analysis
  7.3.2 Personal Use of Biologics and Biosimilars Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF BIOLOGICS AND BIOSIMILARS

8.1 Pfizer
  8.1.1 Company Basic Information, Manufacturing Base and Competitors
  8.1.2 Product Picture and Specifications
  8.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.1.4 Business Overview
8.2 Roche
  8.2.1 Company Basic Information, Manufacturing Base and Competitors
  8.2.2 Product Picture and Specifications
  8.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.2.4 Business Overview
8.3 Amgen
  8.3.1 Company Basic Information, Manufacturing Base and Competitors
  8.3.2 Product Picture and Specifications
  8.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.3.4 Business Overview
8.4 AbbVie
  8.4.1 Company Basic Information, Manufacturing Base and Competitors
  8.4.2 Product Picture and Specifications
  8.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.4.4 Business Overview
8.5 Sanofi
  8.5.1 Company Basic Information, Manufacturing Base and Competitors
  8.5.2 Product Picture and Specifications
  8.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.5.4 Business Overview
8.6 Johnson & Johnson
  8.6.1 Company Basic Information, Manufacturing Base and Competitors
  8.6.2 Product Picture and Specifications
  8.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.6.4 Business Overview
8.7 Novo Nordisk
  8.7.1 Company Basic Information, Manufacturing Base and Competitors
  8.7.2 Product Picture and Specifications
  8.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.7.4 Business Overview
8.8 Novartis
  8.8.1 Company Basic Information, Manufacturing Base and Competitors
  8.8.2 Product Picture and Specifications
  8.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.8.4 Business Overview
8.9 company
  8.9.1 Company Basic Information, Manufacturing Base and Competitors
  8.9.2 Product Picture and Specifications
  8.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.9.4 Business Overview

9 DEVELOPMENT TREND OF ANALYSIS OF BIOLOGICS AND BIOSIMILARS MARKET

9.1 Global Biologics and Biosimilars Market Trend Analysis
  9.1.1 Global 2017-2021 Biologics and Biosimilars Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2021 Biologics and Biosimilars Sales Price Forecast
9.2 Biologics and Biosimilars Regional Market Trend
  9.2.1 North America 2017-2021 Biologics and Biosimilars Consumption Forecast
  9.2.2 China 2017-2021 Biologics and Biosimilars Consumption Forecast
  9.2.3 Europe 2017-2021 Biologics and Biosimilars Consumption Forecast
  9.2.4 Southeast Asia 2017-2021 Biologics and Biosimilars Consumption Forecast
  9.2.5 Japan 2017-2021 Biologics and Biosimilars Consumption Forecast
  9.2.6 India 2017-2021 Biologics and Biosimilars Consumption Forecast
9.3 Biologics and Biosimilars Market Trend (Product Type)
9.4 Biologics and Biosimilars Market Trend (Application)

10 BIOLOGICS AND BIOSIMILARS MARKETING TYPE ANALYSIS

10.1 Biologics and Biosimilars Regional Marketing Type Analysis
10.2 Biologics and Biosimilars International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Biologics and Biosimilars by Regions
10.4 Biologics and Biosimilars Supply Chain Analysis

11 CONSUMERS ANALYSIS OF BIOLOGICS AND BIOSIMILARS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis


12 APPENDIX
LIST OF TABLES AND FIGURES

Figure Picture of Biologics and Biosimilars
Table Product Specifications of Biologics and Biosimilars
Table Classification of Biologics and Biosimilars
Figure Global Production Market Share of Biologics and Biosimilars by Type in 2016
Table Applications of Biologics and Biosimilars
Figure Global Consumption Volume Market Share of Biologics and Biosimilars by Application in 2016
Figure Market Share of Biologics and Biosimilars by Regions
Figure North America Biologics and Biosimilars Market Size (2011-2021)
Figure China Biologics and Biosimilars Market Size (2011-2021)
Figure Europe Biologics and Biosimilars Market Size (2011-2021)
Figure Southeast Asia Biologics and Biosimilars Market Size (2011-2021)
Figure Japan Biologics and Biosimilars Market Size (2011-2021)
Figure India Biologics and Biosimilars Market Size (2011-2021)
Table Biologics and Biosimilars Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Biologics and Biosimilars in 2016
Figure Manufacturing Process Analysis of Biologics and Biosimilars
Figure Industry Chain Structure of Biologics and Biosimilars
Table Capacity and Commercial Production Date of Global Biologics and Biosimilars Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Biologics and Biosimilars Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Biologics and Biosimilars Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Biologics and Biosimilars Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Biologics and Biosimilars 2012-2017
Figure Global 2012-2017 Biologics and Biosimilars Market Size (Volume) and Growth Rate
Figure Global 2012-2017 Biologics and Biosimilars Market Size (Value) and Growth Rate
Table 2012-2017 Global Biologics and Biosimilars Capacity and Growth Rate
Table 2016 Global Biologics and Biosimilars Capacity List (Company Segment)
Table 2012-2017 Global Biologics and Biosimilars Sales and Growth Rate
Table 2016 Global Biologics and Biosimilars Sales List (Company Segment)
Table 2012-2017 Global Biologics and Biosimilars Sales Price
Table 2016 Global Biologics and Biosimilars Sales Price List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption of Biologics and Biosimilars 2012-2017
Figure North America 2012-2017 Biologics and Biosimilars Sales Price
Figure North America 2016 Biologics and Biosimilars Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption of Biologics and Biosimilars 2012-2017
Figure China 2012-2017 Biologics and Biosimilars Sales Price
Figure China 2016 Biologics and Biosimilars Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption of Biologics and Biosimilars 2012-2017
Figure Europe 2012-2017 Biologics and Biosimilars Sales Price
Figure Europe 2016 Biologics and Biosimilars Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption of Biologics and Biosimilars 2012-2017
Figure Southeast Asia 2012-2017 Biologics and Biosimilars Sales Price
Figure Southeast Asia 2016 Biologics and Biosimilars Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption of Biologics and Biosimilars 2012-2017
Figure Japan 2012-2017 Biologics and Biosimilars Sales Price
Figure Japan 2016 Biologics and Biosimilars Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption of Biologics and Biosimilars 2012-2017
Figure India 2012-2017 Biologics and Biosimilars Sales Price
Figure India 2016 Biologics and Biosimilars Sales Market Share
Table Global 2012-2017 Biologics and Biosimilars Sales by Type
Table Different Types Biologics and Biosimilars Product Interview Price
Table Global 2012-2017 Biologics and Biosimilars Sales by Application
Table Different Application Biologics and Biosimilars Product Interview Price
Table Pfizer Basic Information List
Table Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Biologics and Biosimilars Global Market Share (2012-2017)
Table Roche Basic Information List
Table Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Biologics and Biosimilars Global Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Biologics and Biosimilars Global Market Share (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AbbVie Biologics and Biosimilars Global Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Biologics and Biosimilars Global Market Share (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Johnson & Johnson Biologics and Biosimilars Global Market Share (2012-2017)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novo Nordisk Biologics and Biosimilars Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Biologics and Biosimilars Global Market Share (2012-2017)
Table company 9 Basic Information List
Table company 9 Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure company 9 Biologics and Biosimilars Global Market Share (2012-2017)
Figure Global 2017-2021 Biologics and Biosimilars Market Size (Volume) and Growth Rate Forecast
Figure Global 2017-2021 Biologics and Biosimilars Market Size (Value) and Growth Rate Forecast
Figure Global 2017-2021 Biologics and Biosimilars Sales Price Forecast
Figure North America 2017-2021 Biologics and Biosimilars Consumption Volume and Growth Rate Forecast
Figure China 2017-2021 Biologics and Biosimilars Consumption Volume and Growth Rate Forecast
Figure Europe 2017-2021 Biologics and Biosimilars Consumption Volume and Growth Rate Forecast
Figure Southeast Asia 2017-2021 Biologics and Biosimilars Consumption Volume and Growth Rate Forecast
Figure Japan 2017-2021 Biologics and Biosimilars Consumption Volume and Growth Rate Forecast
Figure India 2017-2021 Biologics and Biosimilars Consumption Volume and Growth Rate Forecast
Table Global Sales Volume of Biologics and Biosimilars by Types 2017-2021
Table Global Consumption Volume of Biologics and Biosimilars by Applications 2017-2021
Table Traders or Distributors with Contact Information of Biologics and Biosimilars by Regions


More Publications